Avricore Health (AVCRF) EBITDA Margin (2015 - 2025)
Avricore Health (AVCRF) reported EBITDA Margin of 1005.97% for Q3 2025, down 99099.0% year-over-year from N/an in Q3 2024, and up 37.21% quarter-over-quarter from 1602.16% in Q2 2025.
Avricore Health (AVCRF) EBITDA Margin (2015 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 11 years of EBITDA Margin data on file, last reported at 1005.97% in Q3 2025.
- EBITDA Margin for Q3 2025 came in at 1005.97%, down 99099.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 64.59% (down 6701.0% YoY), and the FY2025 annual result was 348.17%, down 33419.0% from the prior year.
- EBITDA Margin rose to 1005.97% in Q3 2025 per AVCRF's latest filing, from 1602.16% in the prior quarter.
- Over five years, EBITDA Margin peaked at 20.38% in Q1 2023 and troughed at 1602.16% in Q2 2025.
- A 5-year average of 278.53% and a median of 30.96% in 2022 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2025: EBITDA Margin surged 121135 bps in 2022, then tumbled 160733 bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 115.12% in 2021, then jumped by 79 bps to 24.43% in 2022, then soared by 121 bps to 5.07% in 2023, then tumbled by 396 bps to 14.98% in 2024, then plunged by 6614 bps to 1005.97% in 2025.
- Business Quant data shows AVCRF's EBITDA Margin at 1005.97% in Q3 2025, 1602.16% in Q2 2025, and 17.81% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 31.78% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 21.74% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -12.21% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 12.38% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 19.42% |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,005.97% |
| Jun 30, 2025 | -1,602.16% |
| Mar 31, 2025 | -17.81% |
| Sep 30, 2024 | -14.98% |
| Jun 30, 2024 | 5.17% |
| Mar 31, 2024 | 14.99% |
| Dec 31, 2023 | 5.07% |
| Sep 30, 2023 | -29.84% |
| Jun 30, 2023 | -51.85% |
| Mar 31, 2023 | 20.38% |
| Dec 31, 2022 | -24.43% |
| Sep 30, 2022 | -32.07% |
| Jun 30, 2022 | -119.12% |
| Mar 31, 2022 | -57.87% |
| Dec 31, 2021 | -115.12% |
| Sep 30, 2021 | -23.27% |
| Jun 30, 2021 | -1,330.47% |
| Mar 31, 2021 | -634.28% |
| Dec 31, 2020 | -364.32% |
| Sep 30, 2020 | -189.16% |